Individual Investor

Patrick Soon-Shiong

Signal active

Chairman

Bio

Patrick Soon-Shiong is the Executive Chairman of ImmunityBio. He previously worked at Wibbitz as a Board member. Patrick Soon-Shiong attended the University of the Witwatersrand.

Location

Los Angeles, California, United States, North America

Social

Primary Organization

N/A

Jobs history

NantKwest

Founder

2002 - Invalid date

Los Angeles Times Media Group

President

Invalid date - Current

ImmunityBio

Executive Chairman of the Board

2021 - Current

Board and Advisor Roles

N/A

Invest in regions

Profile Resume

Patrick Soon-Shiong is the Chairman at Chan Soon-Shiong Family Foundation, based in United States, North America. With a background in Finance, Patrick Soon-Shiong has a rich history of leadership and innovation. Patrick Soon-Shiong studied Bachelor's Surgery @ University of the Witwatersrand. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

Edgar Bronfman Jr.

Co-Founder, Chairman & General Partner

Troy Carter

Founder and CEO

Mark Attanasio

Managing Partner

Michael Lynch

Founder

Bo Feng

Managing Partner

Alexis Ohanian

President and Founder

Investment portfolio

Patrick Soon-Shiong has made 11 investments. Their Latest investment was Series A - Heliogen on Apr 08, 2020

Number of investment

Number of exits

Personal investment

Annouced Date	Organization Name	Funding Round	Money Raised
Oct 09, 2018	Heliogen	Series A - Heliogen	10.0M
Jan 30, 2019	Directa Plus	Post-IPO Equity - Directa Plus	0
Mar 26, 2019	NantKwest	Post-IPO Equity - NantKwest	39.0M
Apr 08, 2020	Heliogen	Series A - Heliogen	25.0M

Partner investment

Annouced Date	Organization Name	Funding Round	Investor Name	Money Raised
Jan 01, 2015	-	Private Equity Round - NantiBodyFc	NantWorks	10.0M
May 21, 2015	Wibbitz	Series B - Wibbitz	NantMobile	8.0M
Oct 23, 2017	Wibbitz	Series C - Wibbitz	NantMobile	20.0M
Jan 19, 2018	PacketFabric	Series B - PacketFabric	NantCapital	25.0M

Exits

Prizeo

Platform for influencers to fundraise for their favorite causes through the offering of once-in-a-lifetime experiences a...

Zoom

Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and co...

ImmunityBio

NantCel is an offshoot of Soon-Shiong's NantWorks conglomerate, developing molecular-level cell-based treatments for dis...

Heliogen

Heliogen is a renewable energy technology company focused on eliminating the need for fossil fuels in heavy industry and...

NantKwest

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a bi...

Directa Plus

Directa Plus is a nanotechnology company, manufactures nanoparticles....

Invest in industries

Recent Activity

There is no recent news or activity for this profile.